Drug-price Transparency in Communications (DTC) Act
- Last Action
- 5/13/2019
Actions
- 2019-05-13Read twice and referred to the Committee on Finance. (text: CR S2791)
- 2019-05-13Introduced in Senate
CRS Summary
As of 2019-05-13 (00)
Drug-price Transparency in Communications (DTC) Act
This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
Subjects
- Consumer affairs
- Health care costs and insurance
- Inflation and prices
- Marketing and advertising
- Medicaid
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.